Position in IBRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$7,670
+$5,690 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MTM Investment Management, LLC holds $127,258 across 15 Biotechnology names. IBRX ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
117 | $52,245 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
258 | $19,373 | |
| 3 | FBIO |
Fortress Biotech, Inc.
|
4,249 | $11,854 | |
| 4 | PRME |
Prime Medicine, Inc.
|
3,090 | $10,753 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
1,870 | $9,770 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10 | $7,726 | |
| 7 | IBRX |
ImmunityBio, Inc.
This page
|
1,000 | $7,670 | |
| 8 | NKTR |
Nektar Therapeutics
|
66 | $4,748 |
All Filings in IBRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,670 | 1,000 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,980 | 1,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,460 | 1,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,640 | 1,000 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||